Regeneron Pharmaceuticals Inc (REGN)
748.09
+3.59
(+0.48%)
USD |
NASDAQ |
Nov 22, 10:51
Regeneron Pharmaceuticals Total Return Level: 744.50 for Nov. 21, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 21, 2024 | 744.50 |
November 20, 2024 | 743.35 |
November 19, 2024 | 744.60 |
November 18, 2024 | 762.00 |
November 15, 2024 | 756.81 |
November 14, 2024 | 782.51 |
November 13, 2024 | 804.33 |
November 12, 2024 | 821.00 |
November 11, 2024 | 825.68 |
November 08, 2024 | 828.42 |
November 07, 2024 | 824.48 |
November 06, 2024 | 816.65 |
November 05, 2024 | 829.43 |
November 04, 2024 | 828.84 |
November 01, 2024 | 843.60 |
October 31, 2024 | 838.20 |
October 30, 2024 | 922.79 |
October 29, 2024 | 927.33 |
October 28, 2024 | 928.61 |
October 25, 2024 | 933.02 |
October 24, 2024 | 928.90 |
October 23, 2024 | 941.39 |
October 22, 2024 | 962.34 |
October 21, 2024 | 968.50 |
October 18, 2024 | 990.68 |
Date | Value |
---|---|
October 17, 2024 | 998.23 |
October 16, 2024 | 1007.96 |
October 15, 2024 | 1016.53 |
October 14, 2024 | 1014.25 |
October 11, 2024 | 1015.67 |
October 10, 2024 | 999.02 |
October 09, 2024 | 1012.19 |
October 08, 2024 | 1005.26 |
October 07, 2024 | 996.05 |
October 04, 2024 | 1012.82 |
October 03, 2024 | 1014.59 |
October 02, 2024 | 1040.27 |
October 01, 2024 | 1046.91 |
September 30, 2024 | 1051.24 |
September 27, 2024 | 1042.69 |
September 26, 2024 | 1039.96 |
September 25, 2024 | 1031.15 |
September 24, 2024 | 1045.98 |
September 23, 2024 | 1091.98 |
September 20, 2024 | 1145.03 |
September 19, 2024 | 1150.19 |
September 18, 2024 | 1138.81 |
September 17, 2024 | 1146.75 |
September 16, 2024 | 1153.08 |
September 13, 2024 | 1153.35 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
336.18
Minimum
Jan 30 2020
1201.76
Maximum
Aug 27 2024
693.21
Average
652.06
Median
Total Return Level Benchmarks
Amgen Inc | 412.05 |
Eli Lilly and Co | 2168.95 |
Pfizer Inc | 89.74 |
Biogen Inc | 158.01 |
AbbVie Inc | 279.19 |